Nitrovasodilators are pro-drugs able to release nitric oxide. They have been used in clinical practice for about 100 years and they are still widely used in the treatment of several diseases such as angina pectoris, acute pulmonary edema, and hypertensive crises. This article discusses the pharmacological differences of nitrovasodilators, describes the biochemical pathway of nitric oxide formation, and suggests some criteria to achieve the best therapeutic results.
|Translated title of the contribution||Nitrovasodilators and nitric oxide|
|Number of pages||4|
|Journal||Italian Heart Journal Supplement|
|Publication status||Published - 2000|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine